Evaluate Options Against Venture DNA and Criteria
The founder subjects each pivot option to rigorous stress-testing against the venture's core purpose, market viability criteria, and unit economic boundaries. They evaluate whether each proposed shift aligns with long-term strategic ambitions and founder capabilities.
Testing against venture DNA ensures that potential strategic shifts remain commercially attractive and aligned with team capability. It stops the venture from pivoting into low-margin, unscalable, or misaligned opportunities out of sheer frustration.
A detailed assessment matrix grading each pivot pathway against target market size, margin profile, competitive defensibility, and founder alignment. Clear pass or fail markings must be documented alongside explicit threshold requirements.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
How does each pivot option measure up against your venture's non-negotiable scale, margin, and venture-return benchmarks?
- 2
To what extent does this proposed strategic direction align with the core expertise and long-term vision of the founding team?
- 3
What critical venture DNA principles would be compromised or abandoned if you execute option A versus option B?
- 4
How do you know the total addressable market in this new direction justifies the dilution of equity and resource re-allocation?
- 5
Where does the proposed option risk transforming a high-potential technology into a low-margin services business?